Malignancies and false-positive serological results for hydatidosis.

Por Mansueto, S, Migneco, G, La Cascia, C, Miceli, M D
Publicado em 1980

Serum Levels of Soluble IL-2R, CD4 and CD8 in Chronic Active HCV Positive Hepatitis

Por Caruso, C., Candore, G., Cigna, D., Tripi, S., Di Gaetano, G., Migneco, G., Montalto, G., Ruggieri, I., Notarbartolo, A.
Publicado em 1994

Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia

Por Parrish, C, Scott, G B, Migneco, G, Scott, K J, Steele, L P, Ilett, E, West, E J, Hall, K, Selby, P J, Buchanan, D, Varghese, A, Cragg, M S, Coffey, M, Hillmen, P, Melcher, A A, Errington-Mais, F
Publicado no Leukemia (2015)

OP25 INTRAVENOUS DELIVERY OF ONCOLYTIC REOLYSIN(®) TO PRIMARY AND SECONDARY BRAIN TUMOURS

Por Jebar, A., West, E., Scott, K., Nuovo, G., Fuller, M., Thomson, S., Corns, R., Mathew, R., SivaKumar, G., Cockle, J., Van Hille, P., Errington, F., Appleton, E., Migneco, G., Taggart, D., Coffey, M., Rose, A., Griffin, S., Anth, Ralph C.
Publicado no Neuro Oncol (2015)